Perrigo PRGO Stock
Perrigo Price Chart
Perrigo PRGO Financial and Trading Overview
| Perrigo stock price | 15.96 USD |
| Previous Close | 16.37 USD |
| Open | 16.22 USD |
| Bid | 15 USD x 70000 |
| Ask | 16.75 USD x 80000 |
| Day's Range | 15.88 - 16.33 USD |
| 52 Week Range | 9.23 - 22.01 USD |
| Volume | 1.56M USD |
| Avg. Volume | 2.78M USD |
| Market Cap | 2.21B USD |
| Beta (5Y Monthly) | 0.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.28 USD |
| Forward Dividend & Yield | 1.16 (7.27%) |
| Ex-Dividend Date | August 28, 2026 |
| 1y Target Est | 16.5 USD |
PRGO Valuation Measures
| Enterprise Value | 5.29B USD |
| Trailing P/E | N/A |
| Forward P/E | 6.679725 |
| PEG Ratio (5 yr expected) | 1.14 |
| Price/Sales (ttm) | 0.53433305 |
| Price/Book (mrq) | 0.8799206 |
| Enterprise Value/Revenue | 1.277 |
| Enterprise Value/EBITDA | 8.597 |
Trading Information
Perrigo Stock Price History
| Beta (5Y Monthly) | 0.69 |
| 52-Week Change | -27.25% |
| S&P500 52-Week Change | 10.88% |
| 52 Week High | 22.01 USD |
| 52 Week Low | 9.23 USD |
| 50-Day Moving Average | 14.57 USD |
| 200-Day Moving Average | 12.42 USD |
PRGO Share Statistics
| Avg. Volume (3 month) | 2.78M USD |
| Avg. Daily Volume (10-Days) | 2.43M USD |
| Shares Outstanding | 138.77M |
| Float | 138.07M |
| Short Ratio | 8.4 |
| % Held by Insiders | 0.39% |
| % Held by Institutions | 115.35% |
| Shares Short | 24.24M |
| Short % of Float | 26.79% |
| Short % of Shares Outstanding | 17.46% |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.16 |
| Trailing Annual Dividend Yield | 7.08% |
| 5 Year Average Dividend Yield | 375.00% |
| Payout Ratio | 13.4875 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 27, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -41.85% |
| Operating Margin (ttm) | 3.84% |
| Gross Margin | 33.26% |
| EBITDA Margin | 14.85% |
Management Effectiveness
| Return on Assets (ttm) | 1.97% |
| Return on Equity (ttm) | -48.74% |
Income Statement
| Revenue (ttm) | 4.14B USD |
| Revenue Per Share (ttm) | 29.83 USD |
| Quarterly Revenue Growth (yoy) | -3.20% |
| Gross Profit (ttm) | 1.38B USD |
| EBITDA | 615.5M USD |
| Net Income Avi to Common (ttm) | -1703200000 USD |
| Diluted EPS (ttm) | -12.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 399.7M USD |
| Total Cash Per Share (mrq) | 2.88 USD |
| Total Debt (mrq) | 3.48B USD |
| Total Debt/Equity (mrq) | 138.18 USD |
| Current Ratio (mrq) | 2.324 |
| Book Value Per Share (mrq) | 18.138 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 196.1M USD |
| Levered Free Cash Flow (ttm) | 437.21M USD |
Profile of Perrigo
| Country | United States |
| State | N/A |
| City | Dublin |
| Address | The Sharp Building |
| ZIP | D02 TY74 |
| Phone | 353 1 709 4000 |
| Website | https://www.perrigo.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 8100 |
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Q&A For Perrigo Stock
What is a current PRGO stock price?
Perrigo PRGO stock price today per share is 15.96 USD.
How to purchase Perrigo stock?
You can buy PRGO shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Perrigo?
The stock symbol or ticker of Perrigo is PRGO.
Which industry does the Perrigo company belong to?
The Perrigo industry is Drug Manufacturers - Specialty & Generic.
How many shares does Perrigo have in circulation?
The max supply of Perrigo shares is 138.77M.
What is Perrigo Price to Earnings Ratio (PE Ratio)?
Perrigo PE Ratio is now.
What was Perrigo earnings per share over the trailing 12 months (TTM)?
Perrigo EPS is -12.28 USD over the trailing 12 months.
Which sector does the Perrigo company belong to?
The Perrigo sector is Healthcare.
Perrigo PRGO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech US Smart Pharmaceuticals
NQSSPH
US
|
2264.93 USD — |
-1.19
|
— — | 2251.22 USD — | 2281.71 USD — | — - | — — |
NYSE Arca Pharmaceutical Index
DRG
US
|
1298.72 USD — |
-1.6
|
— — | — — | — — | — - | — — |
US Tech US Broad Dividend Achiev
DAA
US
|
4654.81 USD — |
-0.76
|
— — | 4641.75 USD — | 4673.2 USD — | — - | — — |
NYSE Composite Index
NYA
US
|
24117.27 USD — |
-0.65
|
— — | — — | — — | — - | — — |
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
US Tech US Broad Dividend Achiev
DAATR
US
|
8778.75 USD — |
-0.76
|
— — | 8754.13 USD — | 8813.43 USD — | — - | — — |
- {{ link.label }} {{link}}


